Published: 16 July 2026
Author(s): Rosa Talerico, Francesco Mancinetti, Clara Sacco, Matteo Mazzetti, Elena Campello, Simone Birocchi, Sofia Beccatini, Angelo Porfidia, Corrado Lodigiani, Paolo Simioni, Gian Marco Podda, Isabella Mastandrea, Cecilia Becattini, Roberto Pola, Maria Cristina Vedovati
Section: Original Article
Data on safety and effectiveness of direct oral anticoagulants (DOACs) in patients with cancer-associated thrombosis (CAT) and impaired functional status are limited. We evaluated the impact of Eastern Cooperative Oncology Group (ECOG) performance status on bleeding and thrombotic events in a real-world cohort.
